Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - mycoplasma synoviae strain ms-h vaccine, living - misc. aural, ophthalmic, oro/naso pharyngeal - mycoplasma synoviae strain ms-h vaccine, living vaccine-general active 105.7 ccu/dose - immunotherapy - poultry broilers (meat for human consum) | poultry layers (eggs for human consump) | poultry pullets (growing chook) | breeding - airsacculitis | chronic respiratory disease | infectious synovitis | vaccine | equine rotavirus | ms

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - betamethasone valerate 0.1%{relative}; clioquinol 3%{relative};   - topical cream - 0.1%/3% - active: betamethasone valerate 0.1%{relative} clioquinol 3%{relative}   - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r) - tretinoin 0.2 mg in 1 g - (to understand fully the indication for this product, please read the entire indications and usage section of the labeling.) renova® (tretinoin cream) 0.02% is indicated as an adjunctive agent (see second bullet point below) for use in the mitigation (palliation) of fine facial wrinkles in patients who use comprehensive skin care and sunlight avoidance programs. renova® (tretinoin cream) 0.02% does not eliminate wrinkles, repair sun-damaged skin, reverse photoaging, or restore more youthful or younger skin. in double-blinded, vehicle-controlled clinical studies, many patients in the vehicle group achieved desired palliative effects on fine wrinkling of facial skin with the use of comprehensive skin care and sunlight avoidance programs including sunscreens, protective clothing, and non-prescription emollient creams. - renova® (tretinoin cream) 0.02% has not demonstrated a mitigating effect on significant signs of chronic sunlight exposure such as coarse or deep wrinkling, tactile roughness, mottled hype

United States - English - NLM (National Library of Medicine)

bausch health us llc - tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r) - tretinoin 0.2 mg in 1 g - (to understand fully the indication for this product, please read the entire indications and usage section of the labeling.) renova (tretinoin cream) 0.02% is indicated as an adjunctive agent (see second bullet point below) for use in the mitigation (palliation) of fine facial wrinkles in patients who use comprehensive skin care and sunlight avoidance programs. renova (tretinoin cream) 0.02% does not eliminate wrinkles, repair sun-damaged skin, reverse photoaging, or restore more youthful or younger skin. in double-blind, vehicle-controlled clinical studies, many patients in the vehicle group achieved desired palliative effects on fine wrinkling of facial skin with the use of comprehensive skin care and sunlight avoidance programs including sunscreens, protective clothing, and non-prescription emollient creams. four adequate and well-controlled multi-center trials and one single-center randomized, controlled trial were conducted involving a total of 324 evaluable patients treated with renova (tretinoin crea

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - betamethasone valerate 0.122%{relative} equivalent to 0.1% betamethasone - lotion - 0.1 % - active: betamethasone valerate 0.122%{relative} equivalent to 0.1% betamethasone excipient: cetomacrogol 1000 cetostearyl alcohol citric acid monohydrate glycerol isopropyl alcohol liquid paraffin methyl hydroxybenzoate purified water sodium citrate dihydrate xanthan gum - betnovate lotion is a potent topical corticosteroid indicated foradults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses. these include the following: ·atopic dermatitis (including infantileatopic dermatitis) ·nummular dermatitis (discoid eczema) ·prurigo nodularis ·psoriasis (excluding widespread plaque psoriasis) ·lichen simplex chronicus (neurodermatitis) and lichen planus ·seborrhoeic dermatitis ·irritant or allergic contact dermatitis ·discoid lupus erythematosus ·insect bite reactions ·miliaria (prickly heat); and ·adjunct to systemic steroid therapy in generalised erythroderma.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - betamethasone as valerate - solution - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - steroid responsive dermatoses of the scalp, such as psoriasis, seborrheic capitis and inflammation associated with severe dandruff.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 1.22 mg/g (equivalent: betamethasone, qty 1 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - cream - excipient ingredients: cetomacrogol 1000; cetostearyl alcohol; white soft paraffin; liquid paraffin; purified water; chlorocresol; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - betamethasone valerate -